To promote translational research on LOX towards greater clinical significance, in this study, we address the following questions: how is LOX associated with metastasis and estrogen receptor 1 (ESR1) expression; why does bisphosphonate inhibit metastasis in patients overexpressing LOX; and are there any promising therapeutic options for managing LOX+ ER– breast cancer patients. Here, ESR1 is linked to breast cancer.